Preview
Unable to display preview. Download preview PDF.
References
Jevons MP (1961) Celbin-resistant staphylococci. BMJ 1:124–125
National Nosocomial Infections Surveillance (NNIS) System Report (2003) Data summary from January 1992 through June 2003, issued August 2003. Am J Infect Control 31:481–498
Romero-Vivas J, Rubio M, Fernandez C, Picazo JJ (1995) Mortality associated with nosocomial bacteremia due to methicillin-resistant Staphylococcus aureus. Clin Infect Dis 21:1417–1423
Pujol M, Pena C, Pallares R, et al (1996) Nosocomial Staphylococcus aureus bacteremia among nasal carriers of methicillin-resistant and methicillin-susceptible strains. Am J Med 100:509–516
Steinberg JP, Clark CC, Hackman BO (1996) Nosocomial and community-acquired Staphylococcus aureus bacteremias from 1980 to 1993: impact of intravascular devices and methicillin resistance. Clin Infect Dis 23:255–259
Rello J, Torres A, Ricart M, et al (1994) Ventilator-associated pneumonia by Staphylococcus aureus. Comparison of methicillin-resistant and methicillin-sensitive episodes. Am J Respir Crit Care Med 150:1545–1549
Mekontso-Dessap A, Kirsch M, Brun-Buisson C, Lcisance D (2001) Poststernotomy mediastinitis due to Staphylococcus aureus: comparison of methicillin-resistant and methicillin-susceptible cases. Clin Infect Dis 32:877–883
Blot SI, Vandewoude KH, Hoste EA, Colardyn FA (2002) Outcome and attributable mortality in critically ill patients with bacteremia involving methicillin-susceptible and methicillin-resistant Staphylococcus aureus. Arch Intern Med 162:2229–2235
Talon D, Woronoff-Lemsi MC, Limat S, et al (2002) The impact of resistance to methicillin in Staphylococcus aureus bacteremia on mortality. Eur J Intern Med 13:31–36
Conterno LO, Wey SB, Castelo A (1998) Risk factors for mortality in Staphylococcus aureus bacteremia. Infect Control Hosp Epidemiol 19:32–37
Ibelings MM, Bruining HA (1998) Methicillin-resistant Staphylococcus aureus: acquisition and risk of death in patients in the intensive care unit. Eur J Surg 164:411–418
Engemann JJ, Carmeli Y, Cosgrove SE, et al (2003) Adverse clinical and economic outcomes attributable to methicillin resistance among patients with Staphylococcus aureus surgical site infection. Clin Infect Dis 36:592–598
Cosgrove SE, Sakouias G, Perencevich EN, Schwaber MJ, Karchmer AW, Carmeli Y (2003) Comparison of mortality associated with methicillin-resistant and methicillin-susceptible Staphylococcus aureus bacteremia: a meta-analysis. Clin Infect Dis 36:53–59
Harbarth S, Rutschmann O, Sudre P, Pittet D (1998) Impact of methicillin resistance on the outcome of patients with bacteremia caused by Staphylococcus aureus. Arch Intern Med 158:182–189
Tumbarello M, De Gaetano Donati K, Tacconelli E, et al (2002) Risk factors and predictors of mortality of methicillin-resistant Staphylococcus aureus (MRSA) bacteraemia in HIV-infected patients. J Antimicrob Chemother 50:375–382
Soriano A, Martinez JA, Mensa J, et al (2000) Pathogenic significance of methicillin resistance for patients with Staphylococcus aureus bacteremia. Clin Infect Dis 30:368–373
Roghmann MC (2000) Predicting methicillin resistance and the effect of inadequate empiric therapy on survival in patients with Staphylococcus aureus bacteremia. Arch Intern Med 160:1001–1004
Mylotte JM, Tayara A (2000) Staphylococcus aureus bacteremia: predictors of 30-day mortality in a large cohort. Clin Infect Dis 31:1170–1174
Hershow RC, Khayr WF, Smith NL (1992) A comparison of clinical virulence of nosocomially acquired methicillin-resistant and methicillin-sensitive Staphylococcus aureus infections in a university hospital. Infect Control Hosp Epidemiol 13:587–593
Mylotte JM, Aeschlimann JR, Rotella DL (1996) Staphylococcus aureus bacteremia: factors predicting hospital mortality. Infect Control Hosp Epidemiol 17:165–168
Marty L, Flahault A, Suarez B, Caillon J, Hill C, Andremont A (1993) Resistance to methicillin and virulence of Staphylococcus aureus strains in bacteriemic cancer patients. Intensive Care Med 19:285–289
French GL, Cheng AF, Ling JM, Mo P, Donnan S (1990) Hong Kong strains of methicillin-resistant and methicillin-sensitive Staphylococcus aureus have similar virulence. J Hosp Infect 15:117–125
Selvey LA, Whitby M, Johnson B (2000) Nosocomial methicillin-resistant Staphylococcus aureus bacteremia: is it any worse than nosocomial methicillin-sensitive Staphylococcus aureus bacteremia? Infect Control Hosp Epidemiol 21:645–648
Hewitt JH, Sanderson PJ (1974) The effect of methicillin on skin lesions in guinea-pigs caused by methicillin-sensitive and methicillin-resistant Staphylococcus aureus. J Med Microbiol 7:223–235
Peacock JE, Jr., Moorman DR, Wenzel RP, Mandell GL (1981) Methicillin-resistant Staphylococcus aureus: microbiologic characteristics, antimicrobial susceptibilities, and assessment of virulence of an epidemic strain. J Infect Bis 144:575–582
Aathithan S, Dybowski R, French GL (2001) Highly epidemic strains of methicillin-resistant Staphylococcus aureus not distinguished by capsule formation, protein A content or adherence to HEp-2 cells. Eur J Clin Microbiol Infect Dis 20:27–32
Schmitz FJ, MacKenzie CR, Geisel R, et al (1997) Enterotoxin and toxic shock syndrome toxin-1 production of methicillin resistant and methicillin sensitive Staphylococcus aureus strains. Eur J Epidemiol 33:699–708
Laurent F, Lelievre H, Cornu M, et al (2001) Fitness and competitive growth advantage of new gentamicin-susceptible MRSA clones spreading in French hospitals. J Antimicrob Chemother 47:277–283
Duckworth GJ, Tordens JZ (1990) Adherence and survival properties of an epidemic methicillin-resistant strain of Staphylococcus aureus compared with those of methicillin-sensitive strains. J Med Microbiol 32:195–200
Ellis MW, Hospenthal DR, Dooley DP, Gray PJ, Murray CK (2004) Natural history of community-acquired methicillin-resistant Staphylococcus aureus colonization and infection in soldiers. Clin Infect Dis 39:971–979
Okuma K, Iwakawa K, Turnidge JD, et al (2002) Dissemination of new methicillin-resistant Staphylococcus aureus clones in the community. J Clin Microbiol 40:4289–4294
Cosgrove SE, Carmeli Y (2003) The impact of antimicrobial resistance on health and economic outcomes. Clin Infect Dis 36:1433–1437
McCabe WR, Jackson GG (1962) Gram-negative bacteremia. Arch Intern Med 110:847–864
Charlson ME, Pompei P, Ales KL, MacKenzie CR (1987) A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis 40:373–383
Levine DP, Fromm BS, Reddy BR (1991) Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis. Ann Intern Med 115:674–680
Small PM, Chambers HF (1990) Vancomycin for Staphylococcus aureus endocarditis in intravenous drug users. Antimicrob Agents Chemother 34:1227–1231
Cruciani M, Gatti G, Lazzarini L, et al (1996) Penetration of vancomycin into human lung tissue. J Antimicrob Chemother 38:865–869
Lamer C, de Beco V, Soier P, et al (1993) Analysis of vancomycin entry into pulmonary lining fluid by bronchoalveolar lavage in critically ill patients. Antimicrob Agents Chemother 37:281–286
Rodman DP, McKnight JT, Rogers T, Robbins M (1994) The appropriateness of initial vancomycin dosing. J Fam Pract 38:473–477
Conte JE, Jr., Golden JA, Kipps J, Zurlinden E (2002) Intrapulmonary pharmacokinetics of linezolid. Antimicrob Agents Chemother 46:1475–1480
Wunderink RG, Rello J, Cammarata SK, Croos-Dabrera RV, Kollef MH (2003) Linezolid vs vancomycin: analysis of two double-blind studies of patients with methicillin-resistant Staphylococcus aureus nosocomial pneumonia. Chest 124:1789–1797
Stevens DL, Herr D, Lampiris H, Hunt JL, Batts DH, Hafkin B (2002) Linezolid versus vancomycin for the treatment of methicillin-resistant Staphylococcus aureus infections. Clin Infect Dis 34:1481–1490
Gonzalez C, Rubio M, Romero-Vivas J, Gonzalez M, Picazo JJ (1999) Bacteremic pneumonia due to Staphylococcus aureus: a comparison of disease caused by methicillin-resistant and methicillin-susceptible organisms. Clin Infect Dis 29:1171–1177
Kollef MH, Sherman G, Ward S, Fraser VJ (1999) Inadequate antimicrobial treatment of infections: a risk factor for hospital mortality among critically ill patients. Chest 115:462–474
Martone WJ, Nichols RL (2001) Recognition, prevention, surveillance, and management of surgical site infections: introduction to the problem and symposium overview. Clin Infect Dis 33(Suppl 2):S67–68
Gleason TG, Crabtree TD, Pelletier SJ, et al (1999) Prediction of poorer prognosis by infection with antibiotic-resistant gram-positive cocci than by infection with antibiotic-sensitive strains. Arch Surg 134:1033–1040
Combes A, Trouillet JE, Joly-Guillou ML, Chastre J, Gibert C (2004) The impact of methicillin resistance on the outcome of poststernotomy mediastinitis due to Staphylococcus aureus. Clin Infect Dis 38:822–829
Lentino JR, Hennein H, Krause S, et al (1985) A comparison of pneumonia caused by gentamicin, methicillin-resistant and gentamicin, methicillin-sensitive Staphylococcus aureus: epidemiologic and clinical studies. Infect Control 6:267–272
Combes A, Luyt CE, Fagon JY, et al (2004) Impact of methicillin resistance on outcome of Staphylococcus aureus ventilator-associated pneumonia. Am J Respir Crit Care Med 170:786–792
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2005 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Combes, A., Luyt, CE., Trouillet, JL. (2005). Impact of Methicillin Resistance on the Outcome of Severe Staphylococcus aureus Infections. In: Vincent, JL. (eds) Yearbook of Intensive Care and Emergency Medicine 2005. EN]Yearbook of Intensive Care and Emergency Medicine, vol 2005. Springer, New York, NY. https://doi.org/10.1007/0-387-26272-5_31
Download citation
DOI: https://doi.org/10.1007/0-387-26272-5_31
Publisher Name: Springer, New York, NY
Print ISBN: 978-3-540-23476-0
Online ISBN: 978-0-387-26272-7
eBook Packages: MedicineMedicine (R0)